Clinical Trials on GNA11 Mutation-positive Metastatic Melanoma in New Zealand
Total 302 results
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Dermatologic Cooperative Oncology GroupUnknown
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.CompletedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompleted
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States
-
NewLink Genetics CorporationCompletedMetastatic Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
TransMolecularTerminatedMelanoma | Metastatic Melanoma | Malignant MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
VicalCompletedMetastatic MelanomaUnited States
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer Center; Institut Curie Paris; Moffitt Cancer...Active, not recruitingMetastatic Uveal Melanoma | Stage IV Uveal Melanoma AJCC v7United States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic MelanomaUnited States
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationAustralia
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology GroupActive, not recruitingMetastatic MelanomaNorway, Australia, United Kingdom
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
Idera Pharmaceuticals, Inc.CompletedMetastatic MelanomaUnited States
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States